Any changes to a treatment plan must be discussed directly with a primary care physician
You check in with the team on a set schedule, and those follow-ups let your provider see how you are tolerating the medication and adjust the dose up, hold it, or ease it back
Interestingly, GCGR antagonism totally suppressed this response in agreement with the suppression of eWAT lipolysis
Conducted between June 2011 and March 2013 at 191 sites in 27 countries in Europe, North America, South America, Asia, and Australia this was a randomised, placebo-controlled trial designed to evaluate the efficacy and safety of 3mg liraglutide 'injected subcutaneously once daily, as an adjunct to a reduced-calorie diet and increased physical activity, for weight management in overweight or obese adults who did not have diabetes at baseline.' A total of 3,731 individuals participated in the trial, of whom 2,487 were assigned to lifestyle intervention plus liraglutide and 1,244 to lifestyle intervention with a placebo
Some research shows they increase depression risk, while other studies show they alleviate depression symptoms
